Medifast director Jeffrey Rose files initial Form 3

MEDIFAST INC filed an initial insider ownership report for board member Jeffrey Matthew Rose.

Rhea-AI Filing Summary

MEDIFAST INC filed an initial insider ownership report for board member Jeffrey Matthew Rose. This Form 3 identifies Rose as a director of the company but does not list any stock transactions or current share holdings. It is a routine disclosure establishing his status as an insider for future reporting.

Key Terms

reporting person, director, ten percent owner, Form 3

4 terms

reporting person regulatory

""reportingPersons": [ { "name": "Rose Jeffrey Matthew""

director regulatory

""is_director": 1"

ten percent owner regulatory

""is_ten_percent_owner": 0"

Form 3 regulatory

"INSIDER FILING DATA (Form 3)"

Form 3 is the initial public filing that officers, directors and large shareholders must submit to report their ownership of a company’s securities when they become insiders. It acts like an opening inventory sheet that gives investors a starting point to see who holds significant stakes and to spot later trades or potential conflicts of interest, helping assess insider confidence and transparency.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the MED (Medifast Inc) Form 3 filing for Jeffrey Matthew Rose show?

The Form 3 for Jeffrey Matthew Rose shows he is a director of Medifast Inc. It serves as his initial insider ownership report and, in this case, does not list any transactions or specific share holdings.

Did Jeffrey Matthew Rose buy or sell MEDIFAST INC (MED) shares in this Form 3?

No transactions are reported for Jeffrey Matthew Rose in this Form 3. The transaction summary shows zero buys, zero sells, and no other acquisitions or dispositions, indicating this filing is purely an initial status disclosure.

What insider role does Jeffrey Matthew Rose have at MEDIFAST INC (MED)?

Jeffrey Matthew Rose is identified as a director of MEDIFAST INC. The Form 3 marks him as a director, with no officer title and not a ten percent owner, defining his reporting obligations for future insider filings.

Does the MED Form 3 disclose any derivative positions for Jeffrey Matthew Rose?

The Form 3 does not disclose any derivative securities for Jeffrey Matthew Rose. The derivative summary is empty and derivativeTransactionCount is zero, indicating no options or other derivative holdings are reported in this initial statement.

Is the MEDIFAST INC (MED) Form 3 for Jeffrey Matthew Rose a routine filing?

Yes, this Form 3 appears to be a routine initial insider filing. It identifies Jeffrey Matthew Rose as a director of MEDIFAST INC and shows no reported transactions or holdings, which is common when establishing insider status for future reporting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding Insider Trading Forms →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/28/2026 - 07:30 PM EDT Learn about SEC filing dates

SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0104
Estimated average burden
hours per response:			0.5

1. Name and Address of Reporting Person^*

Rose Jeffrey Matthew

(Last) (First) (Middle)

C/O MEDIFAST, INC.

1501 S. CLINTON STREET, SUITE 500

(Street)

BALTIMORE MARYLAND 21224

(City) (State) (Zip)

UNITED STATES

(Country)

2. Date of Event Requiring Statement (Month/Day/Year)
05/19/2026

3. Issuer Name and Ticker or Trading Symbol
MEDIFAST INC [ MED ]

3a. Foreign Trading Symbol

5. If Amendment, Date of Original Filed (Month/Day/Year)

4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

Exhibit List: Exhibit 24 - Limited Power of Attorney

No securities are beneficially owned.

	/s/ James P. Maloney, attorney-in-fact	05/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)